https://www.selleckchem.com/products/Nolvadex.html
studies and 5.9% (95% CI 2.5-13.5) from seven studies, respectively. Other reactions reported included eczema with a pooled incidence of 5.5% (95% CI 3.3-8.9) from 17 studies and skin infections with pooled incidence of 7.9% (95% CI 5.5-11.2) from 11 studies. The incidence of dermatological events in patients with IBD treated with anti-TNF medications is high. The most commonly reported reaction is psoriasis/psoriasiform reaction. Clinicians should be vigilant to dermatological side effects following treatment of IBD with anti-TNF. The
Like
Comment
Share
